Mind Club

Data as of 11.07.2026 · Primary sources linked · NOT INVESTMENT ADVICE

Disease Pipeline Tools GIST

GIST

Programs, trials, and reported response and survival for gastrointestinal stromal tumor.

Data as of 11.07.2026

All studies

Sunitinib

Study 1

Pfizer · Phase 3 · Completed · Enrollment 361

NCT00075218

ArmReported safety
Sunitinib 50 mg, 4 weeks on 2 offn/r
Placebon/r

A count stays a count. This page does not turn a count into a percent.